ProQR Therapeutics N.V. Shares Close the Day 11.2% Lower - Daily Wrap
The company saw its shares close the day 11.2% lower than yesterday, with trading volume higher than its 30 day average.
Mar 24, 2021 by Kwhen Finance Editors
ProQR Therapeutics N.V. shares closed today 11.2% lower than it did at the end of yesterday. The stock is currently up 94.9% year-to-date, up 14.0% over the past 12 months, and up 91.2% over the past five years. Today, the Dow Jones Industrial Average rose 1.4%, and the S&P 500 rose 1.6%.
Trading Activity
- Shares traded as high as $8.87 and as low as $5.19 this week.
- Shares closed 1e+1% below its 52-week high and 1e+2% above its 52-week low.
- Trading volume this week was 438.2% higher than the 10-day average and 1641.5% higher than the 30-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 0.9.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.
- MACD, a trend-following momentum indicator, indicates an upward trend.
- The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
- The company's share price lags the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price lags the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price lags the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| ProQR Therapeutics N.V. | -11.2 | 94.9 | 14.0 | -9.9 | 150.6 |
| Dow Jones Industrial Average | 1.4 | 8.6 | 55.8 | -1.4 | 61.3 |
| S&P 500 Index | 1.6 | 6.3 | 54.0 | -1.5 | 62.9 |
| Health Care | 1.9 | 3.0 | 38.0 | -3.8 | 41.1 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date beats the peer average by -3463.8%
- The company's stock price performance over the past 12 months lags the peer average by -72.3%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| ProQR Therapeutics N.V. | PRQR | 0 | 94.9 | 14.0 | -9.9 | 150.6 |
| Peer Avg | N/A | 4.1 | -2.8 | 50.6 | -33.8 | 68.6 |
| Emergent BioSolutions Inc. | EBS | 16.5 | 5.5 | 84.6 | -31.5 | 86.1 |
| Atara Biotherapeutics Inc | ATRA | 0 | -24.6 | 75.4 | -47.4 | 107.6 |
| Actinium Pharmaceuticals Inc. | ATNM | 0 | 7.8 | 42.3 | -56.2 | 80.9 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: